8-K
filed January 11, 2023, 6:59 PM ET
ticker AHCO
CIK 0001725255
earnings
confidence medium
sentiment neutral
materiality 0.65
AdaptHealth guides FY2023 revenue $3.21-3.29B, adj. EBITDA $690-750M; Q4 prelim near prior ranges
AdaptHealth Corp.
2022-FY EPS reported
$0.33
revenue$2,970,595,000
- FY2023 net revenue guidance $3.210B-3.290B; Adjusted EBITDA $690M-$750M; capex 9-11% of revenue.
- FY2022 net revenue expected near midpoint of $2.950B-$3.010B; Adjusted EBITDA near low end of $620M-$650M.
- Non-acquired net revenue growth for 2023 estimated at 8-10%, driven by stabilizing PAP device supply.
- CEO cites strong demand but notes cost-of-goods inflation and labor pressures across healthcare.
- Full Q4 and FY2022 results scheduled for release February 28, 2023.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
AdaptHealth Corp. reported fiscal year 2023 results: revenue $3.210 billion to $3.290 billion. Guidance initiated.
- Period
- fiscal year 2023
- Revenue
- $3.210 billion to $3.290 billion
- Guidance
- initiated
- Result
- guidance update
Exact text from the filing
Based on current business, market trends, and acquisitions completed to date, the Company is establishing initial guidance for fiscal year 2023 as follows: · Net revenue of $3.210 billion to $3.290 billion; · Adjusted EBITDA of $690 million to $750 million; and · Total capital expenditures are expected to be 9-11% of net revenue. Guidance for fiscal year 2023
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.85
AdaptHealth Corp. reported preliminary financial results for fourth quarter 2022.
- Period
- fourth quarter 2022
- Result
- preliminary results
Exact text from the filing
ADAPTHEALTH PROVIDES Full-year 2023 Guidance AND Preliminary Commentary on Fourth Quarter 2022 REsults
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
AdaptHealth Corp. reported full year 2022 results: revenue net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion.
- Period
- full year 2022
- Revenue
- net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion
- Result
- preliminary results
Exact text from the filing
the Company anticipates net revenue to be near the midpoint of the previously-provided guidance range of $2.950 billion to $3.010 billion
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.